iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax
/PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that it has completed the efficacy evaluation study of BAL200, a novel...